Follow-up of 5-year Old Children Born After PGD

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-01-31

Study Completion Date

2018-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Since 1995, preimplantation genetic diagnosis (PGD) has been performed in The Netherlands for couples at high risk for transmitting severe or lethal genetic conditions or who have experienced multiple miscarriages due to chromosomal translocations. Approximately 260 children have been born after PGD in The Netherlands. Follow-up data on children born after PGD are scarce. Long-term studies on PGD children have not been conducted in The Netherlands. Results of studies in other countries on 2-year old PGD children are reassuring. These children and their parents have normal scores on relevant parameters such as general health, cognitive and socioemotional development, parent-child interaction and parental stress. Studies of good methodological quality of older children have not yet been published.

Objective: Long-term follow-up of children who have been born after PGD in The Netherlands. The primary aim is to assess the safety of PGD with regard to the health and development of the children.

Study design: A cohort study. Study population: 5- and 8 year old children born after PGD in The Netherlands for various indications and their parents. Control groups consist of 5 and 8-year old naturally conceived (NC) children of parents who have considered PGD treatment and 5 and 8-year old children born after in vitro fertilisation/intracytoplasmatic sperm injection (IVF/ICSI), and the parents of the two latter groups of children.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Development of New Prenatal Diagnostic Tests From Maternal Blood

NCT00314691

Hereditary Diseases

TERMINATED NA

Non-invasive Placental Chromosome Exploration of Intrauterine Growth Restriction

NCT05023161

Fetal Growth Retardation

RECRUITING

Non Invasive Prenatal Testing (NIPT) of Single-gene Disorders

NCT02339402

Hereditary Disease

UNKNOWN

Embryo Health Study

NCT04528498

Infertility Hereditary Diseases

RECRUITING

At High-risk for Pre-eclampsia After Assisted Reproductive Technology

NCT05746793

Pre-Eclampsia

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Parents are asked to fill out questionnaires on their own and their child's medical history. A physical examination of the children will be performed, a swab for collection of buccal cells for (future) DNA methylation analysis will be taken and their cognitive and socioemotional development will be assessed. In the 8 years old children cardiovascular status will be evaluated.

Main study parameters: general health, cognitive and socioemotional development, parent-child interaction and parental stress.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness:

The study procedure consists of filling out questionnaires by parents and a one-time visit to the hospital. No invasive interventions will be performed, except 1 tube of blood in the 8 year old group. The risks associated with the study procedure are very small. The results provide more information about the risks of PGD to prospective parents who are considering PGD and to healthcare providers involved in PGD treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Preimplantation Genetic Diagnosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

PGD children

* 5-year old singleton PGD children with Caucasian parents
* Children must have the Dutch language as their mother tongue for participation in the intelligence quotient (IQ) test. Children that do not have Dutch as their mother tongue will be excluded from the IQ test, but can take part in the rest of the procedure

Naturally conceived (NC) children

* 5-year old singleton NC children with Caucasian parents, matched with PGD children on age and sex
* Parents must have attended the PGD clinic in Maastricht for an informative consultation
* Parents must have become pregnant without any assisted reproductive technique
* Children must have the Dutch language as their mother tongue

IVF/ICSI children

* 5-year old singleton IVF/ICSI children with Caucasian parents, matched with PGD children on age and sex
* Children must have the Dutch language as their mother tongue

Exclusion Criteria

PGD children

* Twins or triplets
* Parents of non-Caucasian descent
* Children with known chromosomal abnormalities (e.g. trisomy 21) or gene disorders with childhood expression of symptoms

NC children

* Twins or triplets
* Parents of non-Caucasian descent
* Children with known chromosomal abnormalities or gene disorders with childhood expression of symptoms

IVF/ICSI children

* Twins or triplets
* Parents of non-Caucasian descent
* Children with known chromosomal abnormalities or gene disorders with childhood expression of symptoms

8 years old group Former participants of the study in 5 year old children

Minimum Eligible Age

5 Years

Maximum Eligible Age

5 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes